Isoptin and Cyclophosphamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isoptin (verapamil hydrochloride) and Cyclophosphamide (cyclophosphamide). Common drug interactions include anaemia among females and haemorrhagic stroke among males.

The phase IV clinical study analyzes what interactions people have when they take Isoptin and Cyclophosphamide. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Isoptin?

Isoptin has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 5,539 Isoptin users. Check the latest studies of Isoptin.

What is Cyclophosphamide?

Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.



On Jul, 29, 2026

30 people who take Isoptin and Cyclophosphamide together, and have interactions are studied.

Isoptin and Cyclophosphamide drug interactions.

What are the common drug interactions of Isoptin and Cyclophosphamide, by gender? *:

female:

  1. Anaemia (lack of blood)
  2. Bone marrow failure
  3. Metastases to central nervous system (cancer spreads to central nervous system)
  4. Metastases to lymph nodes (cancer spreads to lymph node)
  5. Metastases to retroperitoneum (cancer spreads to retroperitonium)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Thrombocytopenia (decrease of platelets in blood)
  8. Pyrexia (fever)
  9. Dehydration (dryness resulting from the removal of water)
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

male:

  1. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Confusional state
  4. Groin pain
  5. B-cell lymphoma (blood cancer affecting b cells)
  6. Drug resistance (reduction in effectiveness of a drug)
  7. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Ventricular hypokinesia (muscle of one's heart does not contract as much as most peoples' hearts do)
  10. Disease progression

What are the common drug interactions of Isoptin and Cyclophosphamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Capillary leak syndrome (capillary leaks plasma)
  2. Encephalitis (inflammation of the brain)

50-59:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  3. Escherichia infection (bacterial infection by escherichia coli)
  4. Rectal haemorrhage (bleeding from anus)
  5. Septic shock (shock due to blood infection)
  6. Anaemia (lack of blood)
  7. Bone marrow failure
  8. Metastases to central nervous system (cancer spreads to central nervous system)
  9. Metastases to lymph nodes (cancer spreads to lymph node)
  10. Metastases to retroperitoneum (cancer spreads to retroperitonium)

60+:

  1. Pyrexia (fever)
  2. Dehydration (dryness resulting from the removal of water)
  3. Leukopenia (less number of white blood cells in blood)
  4. Loss of consciousness
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Pleuropericarditis (inflammation of the pleura and pericardium)
  7. Urinary tract infection
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Hypotension (abnormally low blood pressure)
  10. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

What are the existing conditions these people have? *

  1. Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 5 people, 16.67%
  2. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 5 people, 16.67%
  3. Burkitt Lymphoma (cancer of the lymphatic system): 5 people, 16.67%
  4. Ovarian Epithelial Cancer Stage I (cancer is found in one or both of the ovaries): 3 people, 10.00%
  5. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 10.00%
  6. Stable Angina (a constant chest pain): 2 people, 6.67%
  7. Quit Smoking: 2 people, 6.67%
  8. Non-Hodgkin's Lymphoma Unspecified Histology Indolent (malignant (cancer) cells form in the lymph system- unspecified histology indolent): 2 people, 6.67%
  9. High Blood Cholesterol: 2 people, 6.67%
  10. Bone Marrow Conditioning Regimen: 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Isoptin and Cyclophosphamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isoptin and Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isoptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cyclophosphamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isoptin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cyclophosphamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on verapamil hydrochloride and cyclophosphamide (the active ingredients of Isoptin and Cyclophosphamide, respectively), and Isoptin and Cyclophosphamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: